Ryan Walsh, Senior Vice President, Client Services

With over 20 years of pharmaceutical and trade industry experience, Ryan’s expertise covers a wide variety of areas, with a particular focus on market access strategy, pricing and contracting. At RE, Ryan is responsible for marketing and promotional activities, product, and service quality and, most importantly, client development and support.​

Ryan joins Real Endpoints from Novartis where he was a leader in the market access organization with responsibility for access strategy development and execution for the immunology portfolio. ​

Prior to Novartis, Ryan served as an executive at Walgreens, where he led the development and implementation of a portfolio of innovative, multichannel solutions to provide value to global biopharmaceutical manufacturers in the areas of commercial strategy and patient acquisition and retention.​

He’d gone to Walgreens from Merck, where he led various US and Global Market Access groups, and Schering-Plough, where he started his career, and worked in a variety of roles, including market access, sales, and learning and development.